Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways

Phyllis Wachsberger, Randy Burd, Adam P. Dicker

Research output: Contribution to journalReview articlepeer-review

31 Scopus citations


Radiotherapy is one of the most widely used treatments for cancer; however, the development of tumor radioresistance is an ongoing problem. Agents that target tumor angiogenesis are being used in combination with radiotherapy to improve the therapeutic index without a clear understanding of how these agents may affect radiosensitization. This article discusses recently published studies that may shed some light on the underlying signaling mechanisms that are involved in the interactions of antiangiogenic agents with ionizing radiation.

Original languageEnglish (US)
Pages (from-to)1039-1057
Number of pages19
JournalHematology/Oncology Clinics of North America
Issue number5
StatePublished - Oct 2004
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways'. Together they form a unique fingerprint.

Cite this